SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (1725)9/22/2000 12:13:05 PM
From: Allan Harris  Read Replies (1) | Respond to of 52153
 
Re: I also sold some at-the-money January covered calls against part of my CELG holding

Peter, I would be interested in your thinking here, vis a vis your choice of writing at-the-money calls in lieu of out-of-the-money and as far as going out four months, in lieu of multiple writes using nearer-term calls. I've been going back and forth on this and my own intuition says it is a case by case judgment call, but I do wonder how others analyze covered call strategies.

A



To: Biomaven who wrote (1725)9/22/2000 2:00:36 PM
From: nigel bates  Read Replies (1) | Respond to of 52153
 
...Likely the drugs will do well today (at least relative to the techs), and I think it will be pretty bullish for biotechs if they hold up without major sympathetic NAS weakness

It would appear that the lunatics have moved out of their asylum into ours.

nig


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News